{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:07:34Z","timestamp":1756310854327,"version":"3.40.5"},"reference-count":133,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1053\/j.semdp.2024.10.002","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T06:46:51Z","timestamp":1730270811000},"page":"258-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["\"Lobular lesions of the breast: From the classic to the variants\""],"prefix":"10.1053","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7043-949X","authenticated-orcid":false,"given":"Erinn","family":"Downs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Evin","family":"Gulbahce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2024.10.002_bib0001","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.11197","article-title":"Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability","volume":"106","author":"Sarrio","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.2629","article-title":"The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type","volume":"220","author":"Weigelt","year":"2010","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0003","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","article-title":"E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis","volume":"76","author":"Vos","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0004","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","article-title":"E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers","volume":"14","author":"Berx","year":"1995","journal-title":"EMBO J"},{"key":"10.1053\/j.semdp.2024.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1349-7006.1994.tb02902.x","article-title":"Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast","volume":"85","author":"Kanai","year":"1994","journal-title":"Jpn J Cancer Res"},{"key":"10.1053\/j.semdp.2024.10.002_bib0006","first-page":"1731","article-title":"Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas","volume":"143","author":"Moll","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0007","first-page":"987","article-title":"Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma","volume":"142","author":"Gamallo","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0008","first-page":"1919","article-title":"E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain","volume":"13","author":"Berx","year":"1996","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2024.10.002_bib0009","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/hupa.2001.22759","article-title":"Loss of chromosome 16q in lobular carcinoma in situ","volume":"32","author":"Etzell","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0010","first-page":"4721","article-title":"Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia","volume":"58","author":"Lu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2024.10.002_bib0011","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","article-title":"Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships","volume":"10","author":"Sakr","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0012","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/cncr.20273","article-title":"Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma","volume":"100","author":"Hwang","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0013","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/1078-0432.CCR-18-1103","article-title":"Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma","volume":"25","author":"Lee","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2024.10.002_bib0014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s004180000175","article-title":"The catenin, p120ctn, is a common membrane-associated protein in various epithelial and non-epithelial cells and tissues","volume":"114","author":"Golenhofen","year":"2000","journal-title":"Histochem Cell Biol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1083\/jcb.200205115","article-title":"A novel role for p120 catenin in E-cadherin function","volume":"159","author":"Ireton","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0016","doi-asserted-by":"crossref","first-page":"21409","DOI":"10.1074\/jbc.274.30.21409","article-title":"p120(ctn) binds to the membrane-proximal region of the E-cadherin cytoplasmic domain and is involved in modulation of adhesion activity","volume":"274","author":"Ohkubo","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semdp.2024.10.002_bib0017","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/sj.onc.1207439","article-title":"Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions","volume":"23","author":"Sarrio","year":"2004","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2024.10.002_bib0018","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1038\/sj.onc.1208161","article-title":"Emerging roles for p120-catenin in cell adhesion and cancer","volume":"23","author":"Reynolds","year":"2004","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2024.10.002_bib0019","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1083\/jcb.150.3.567","article-title":"p120 catenin regulates the actin cytoskeleton via Rho family GTPases","volume":"150","author":"Noren","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0020","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0002-9440(10)63783-2","article-title":"Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer","volume":"164","author":"Shibata","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0021","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.pai.0000213128.78665.3c","article-title":"The spectrum of morphomolecular abnormalities of the E-cadherin\/catenin complex in pleomorphic lobular carcinoma of the breast","volume":"15","author":"Dabbs","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0022","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","article-title":"Aberrant expression of E-cadherin in lobular carcinomas of the breast","volume":"32","author":"Da Silva","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.humpath.2020.06.002","article-title":"E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations","volume":"102","author":"Grabenstetter","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/his.12869","article-title":"E-cadherin immunohistochemistry in breast pathology: uses and pitfalls","volume":"68","author":"Canas-Marques","year":"2016","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2024.10.002_bib0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.pas.0000213386.63160.3f","article-title":"Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin","volume":"31","author":"Dabbs","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0027","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e3181f01916","article-title":"Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast","volume":"34","author":"Rakha","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0028","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/modpathol.2010.205","article-title":"beta-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation","volume":"24","author":"Geyer","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0029","first-page":"737","volume":"42","author":"Haagensen","year":"1978","journal-title":"Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0030","first-page":"491","article-title":"Lobular carcinoma in situ: A rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0031","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/1097-0142(197706)39:6<2597::AID-CNCR2820390644>3.0.CO;2-E","article-title":"Lobular carcinoma in situ of the breast. An approach to rational treatment","volume":"39","author":"Andersen","year":"1977","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0032","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1148\/radiology.218.2.r01fe32503","article-title":"Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy","volume":"218","author":"Berg","year":"2001","journal-title":"Radiology"},{"key":"10.1053\/j.semdp.2024.10.002_bib0033","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2214\/ajr.157.2.1853802","article-title":"Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features","volume":"157","author":"Beute","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0034","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2214\/ajr.173.2.10430122","article-title":"Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings","volume":"173","author":"Liberman","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0035","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/modpathol.2016.127","article-title":"Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review","volume":"29","author":"Mooney","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0036","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","article-title":"Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease","volume":"22","author":"Page","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0037","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","article-title":"Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study","volume":"361","author":"Page","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2024.10.002_bib0038","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","article-title":"The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions","volume":"136","author":"Coopey","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0039","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.22408","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study","volume":"109","author":"Collins","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0040","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1245\/s10434-012-2534-9","article-title":"Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia\/lobular carcinoma in situ) diagnosed on core needle biopsy","volume":"19","author":"Shah-Khan","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0041","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1053\/j.semdp.2024.10.002_bib0042","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","article-title":"Atypical hyperplastic lesions of the female breast. A long-term follow-up study","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0043","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4","article-title":"Long term risk of breast cancer and relation to other factors","volume":"78","author":"Bodian","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0044","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.11883","article-title":"Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ","volume":"100","author":"Fisher","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0045","unstructured":"Chen Y-Y. Lobular carcinoma in situ. In: WHO Classification of Tumours Editorial Board. Breast tumours [Internet]. In: Lakhani SR, ed. WHO classification of tumours series. Vol 2. Lyon (France): International Agency for Research on Cancer; 2019."},{"key":"10.1053\/j.semdp.2024.10.002_bib0046","first-page":"297","article-title":"Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types","volume":"6","author":"Marshall","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.semdp.2024.10.002_bib0047","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0046-8177(88)80350-2","article-title":"Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk","volume":"19","author":"Page","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0048","unstructured":"Chen Y-Y. Atypical lobular hyperplasia. In: WHO Classification of Tumours Editorial Board. Breast tumours [Internet]. In: Lakhani SR, ed. Vol 2. Lyon (France): International Agency for Research on Cancer; 2019."},{"key":"10.1053\/j.semdp.2024.10.002_bib0049","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-022-03299-3","article-title":"The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS","volume":"481","author":"Brogi","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2024.10.002_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.14829","article-title":"Update on lobular lesions of the breast","volume":"82","author":"Kuba","year":"2023","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2024.10.002_bib0051","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.semdp.2009.12.009","article-title":"Lobular breast carcinoma and its variants","volume":"27","author":"Rakha","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0052","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-004-4493-8","article-title":"Biomarker profile and genetic abnormalities in lobular carcinoma in situ","volume":"90","author":"Mohsin","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0053","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0054","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","article-title":"Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center","volume":"43","author":"Shamir","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","article-title":"Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0056","unstructured":"NCCN Guidelines Version 2.2024 Breast Cancer Risk Reduction: National Comprehensive Cancer Network; 2024."},{"key":"10.1053\/j.semdp.2024.10.002_bib0057","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","article-title":"Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases","volume":"16","author":"Susnik","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0058","doi-asserted-by":"crossref","first-page":"927","DOI":"10.5858\/arpa.2012-0297-OA","article-title":"Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target","volume":"137","author":"D'Alfonso","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2024.10.002_bib0059","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cncr.27841","article-title":"Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision","volume":"119","author":"Murray","year":"2013","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0060","unstructured":"Consensus Guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions: American Society of Breast Surgeons Official Statement; 2016."},{"year":"2024","series-title":"NCCN Guidelines Version 2.2024 Breast Cancer Screening and Diagnosis","key":"10.1053\/j.semdp.2024.10.002_bib0061"},{"key":"10.1053\/j.semdp.2024.10.002_bib0062","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrclinonc.2015.8","article-title":"Current management of lesions associated with an increased risk of breast cancer","volume":"12","author":"Morrow","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0063","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.pas.0000213290.58283.82","article-title":"Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases","volume":"30","author":"Fadare","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0064","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/00000478-200012000-00009","article-title":"Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis","volume":"24","author":"Middleton","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0066","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1309\/AJCPZHZ2TUE2UYNV","article-title":"Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ","volume":"144","author":"Blanco","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0067","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/j.clbc.2017.10.004","article-title":"Pleomorphic Lobular Carcinoma in Situ Diagnosed by Breast Core Biopsy: Clinicopathologic Features and Correlation With Subsequent Excision","volume":"18","author":"Guo","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2024.10.002_bib0068","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1524-4741.2010.00994.x","article-title":"Lobular carcinoma, not only a classic","volume":"16","author":"Brogi","year":"2010","journal-title":"Breast J"},{"key":"10.1053\/j.semdp.2024.10.002_bib0069","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s004280050469","article-title":"Mammographically detected in situ lobular carcinomas of the breast","volume":"436","author":"Sapino","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2024.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41379-021-00796-9","article-title":"Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision","volume":"34","author":"Kuba","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0071","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","article-title":"Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications","volume":"134","author":"Sullivan","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2024.10.002_bib0072","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","article-title":"Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature","volume":"45","author":"Foschini","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0073","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.breast.2013.01.003","article-title":"Challenges in the management of pleomorphic lobular carcinoma in situ of the breast","volume":"22","author":"Masannat","year":"2013","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2024.10.002_bib0074","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.breast.2017.12.011","article-title":"Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ","volume":"38","author":"Masannat","year":"2018","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2024.10.002_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1806","article-title":"Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity","volume":"207","author":"Reis-Filho","year":"2005","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0076","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-015-3336-0","article-title":"Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast","volume":"150","author":"Lien","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0077","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41379-020-0459-6","article-title":"Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations","volume":"33","author":"Harrison","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0078","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/PAS.0000000000001493","article-title":"Apocrine Variant of Pleomorphic Lobular Carcinoma In Situ: Further Clinical, Histopathologic, Immunohistochemical, and Molecular Characterization of an Emerging Entity","volume":"44","author":"Zhong","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0079","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/his.12353","article-title":"Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases","volume":"64","author":"Khoury","year":"2014","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2024.10.002_bib0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","article-title":"Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ","volume":"135","author":"Downs-Kelly","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2024.10.002_bib0081","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.prp.2016.05.002","article-title":"Lobular breast cancer: Clinical, molecular and morphological characteristics","volume":"212","author":"Christgen","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1053\/j.semdp.2024.10.002_bib0082","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/ERC-06-0060","article-title":"Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment","volume":"14","author":"Biglia","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0083","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"Jama"},{"key":"10.1053\/j.semdp.2024.10.002_bib0084","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/1055-9965.EPI-08-1082","article-title":"The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004","volume":"18","author":"Eheman","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.semdp.2024.10.002_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.breast.2014.12.009","article-title":"Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity","volume":"24","author":"Heidinger","year":"2015","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2024.10.002_bib0086","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/jnci\/djn224","article-title":"Comparing screening mammography for early breast cancer detection in Vermont and Norway","volume":"100","author":"Hofvind","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.semdp.2024.10.002_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-007-9528-5","article-title":"MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature","volume":"107","author":"Mann","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0088","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejso.2013.02.007","article-title":"Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)","volume":"39","author":"Biglia","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0089","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-2861-6","article-title":"Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma","volume":"144","author":"Loibl","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejso.2014.09.004","article-title":"Surgical management of lobular carcinoma from a national screening program: a retrospective analysis","volume":"41","author":"Sharma","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0091","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/annonc\/mdr461","article-title":"Outcome of special types of luminal breast cancer","volume":"23","author":"Colleoni","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0092","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1245\/s10434-011-1907-9","article-title":"Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period","volume":"19","author":"Fortunato","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0093","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.breast.2013.06.001","article-title":"The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients","volume":"22","author":"Korhonen","year":"2013","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2024.10.002_bib0094","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10549-012-2160-z","article-title":"Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences","volume":"135","author":"Kwast","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-012-2233-z","article-title":"Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer","volume":"136","author":"Lips","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0096","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jclinpath-2011-200151","article-title":"Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast","volume":"64","author":"Fern\u00e1ndez","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0097","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/1471-2407-10-664","article-title":"The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study","volume":"10","author":"Jung","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0098","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1245\/s10434-010-0953-z","article-title":"Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes","volume":"17","author":"Wasif","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0099","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1477-7819-8-34","article-title":"Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study","volume":"8","author":"Lee","year":"2010","journal-title":"World J Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0100","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials","volume":"26","author":"Pestalozzi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-008-0112-4","article-title":"Lack of prognostic significance of \"classic\" lobular breast carcinoma: a matched, single institution series","volume":"117","author":"Viale","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0102","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.semdp.2024.10.002_bib0103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","article-title":"Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes","volume":"44","author":"Rakha","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0104","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.1997.540","article-title":"Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma","volume":"76","author":"Toikkanen","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8","article-title":"Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns","volume":"77","author":"Sastre-Garau","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0106","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B","article-title":"Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?","volume":"73","author":"Silverstein","year":"1994","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0107","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","article-title":"Invasive lobular carcinoma of the breast: the increasing importance of this special subtype","volume":"23","author":"McCart Reed","year":"2021","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.semdp.2024.10.002_bib0108","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10549-015-3273-y","article-title":"Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin","volume":"149","author":"Braunstein","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.semdp.2024.10.002_bib0109","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/bjs.1800821023","article-title":"Lobular carcinoma of the breast can be managed by breast-conserving therapy","volume":"82","author":"Holland","year":"1995","journal-title":"Br J Surg"},{"key":"10.1053\/j.semdp.2024.10.002_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3816\/CBC.2010.n.007","article-title":"Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma","volume":"10","author":"Silberfein","year":"2010","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0111","first-page":"15","article-title":"Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights","author":"Batra","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semdp.2024.10.002_bib0112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.breast.2021.11.017","article-title":"Kerin MJ. Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery-A systematic review and meta-analysis","volume":"61","author":"O'Connor","year":"2022","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2024.10.002_bib0113","first-page":"74","article-title":"A histologic classification of carcinoma of the breast","volume":"19","author":"Foote","year":"1946","journal-title":"Surgery"},{"key":"10.1053\/j.semdp.2024.10.002_bib0114","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1200\/JCO.2015.64.0334","article-title":"Genomic Characterization of Primary Invasive Lobular Breast Cancer","volume":"34","author":"Desmedt","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.2012.197","article-title":"Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?","volume":"26","author":"Rakha","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0116","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anndiagpath.2015.01.005","article-title":"Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma","volume":"19","author":"Narendra","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0117","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000442884","article-title":"Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases","volume":"83","author":"Rakha","year":"2016","journal-title":"Pathobiology"},{"key":"10.1053\/j.semdp.2024.10.002_bib0118","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.breast.2018.11.007","article-title":"Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma","volume":"43","author":"Haque","year":"2019","journal-title":"Breast"},{"key":"10.1053\/j.semdp.2024.10.002_bib0119","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/WMX7DRWTFVQP2LQT","article-title":"E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters","volume":"125","author":"Qureshi","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7819-3-73","article-title":"Aberrant E-cadherin staining patterns in invasive mammary carcinoma","volume":"3","author":"Harigopal","year":"2005","journal-title":"World J Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0121","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2024.10.002_bib0122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.10176","article-title":"CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk","volume":"98","author":"Lei","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0123","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast","volume":"92","author":"Droufakou","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0124","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.2541","article-title":"Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia","volume":"218","author":"Zou","year":"2009","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcancer.2017.03.007","article-title":"Transcriptomic and genomic features of invasive lobular breast cancer","volume":"44","author":"Desmedt","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.1908","article-title":"PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma","volume":"208","author":"Buttitta","year":"2006","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0127","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.1691","article-title":"Molecular evolution of breast cancer","volume":"205","author":"Simpson","year":"2005","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0128","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","article-title":"A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer","volume":"16","author":"Nielsen","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2024.10.002_bib0129","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"10.1053\/j.semdp.2024.10.002_bib0130","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1245\/s10434-018-6687-z","article-title":"Breast Cancers of Special Histologic Subtypes Are Biologically Diverse","volume":"25","author":"Tadros","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semdp.2024.10.002_bib0131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clbc.2015.08.001","article-title":"Utility of Oncotype DX Risk Assessment in Patients With Invasive Lobular Carcinoma","volume":"16","author":"Tsai","year":"2016","journal-title":"Clin Breast Cancer"},{"key":"10.1053\/j.semdp.2024.10.002_bib0132","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4137\/BMI.S38435","article-title":"Prognostic Value of MammaPrint(\u00ae) in Invasive Lobular Breast Cancer","volume":"11","author":"Beumer","year":"2016","journal-title":"Biomark Insights"},{"key":"10.1053\/j.semdp.2024.10.002_bib0133","series-title":"WHO Classification of Tumours Editorial Board. Breast tumours [Internet]","article-title":"S. Invasive lobular carcinoma","author":"Shin","year":"2019"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257024000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257024000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T20:04:18Z","timestamp":1732046658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257024000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0740257024000893"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2024.10.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"type":"print","value":"0740-2570"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\"Lobular lesions of the breast: From the classic to the variants\"","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}